Browsing Tag
MD Anderson
3 posts
Racura Oncology (ASX:RAC) funds three cancer trials, but can RC220 justify the valuation?
Racura Oncology has funded three RC220 trials, but valuation now depends on clinical proof. Can ASX:RAC turn capital into decisive cancer data?
Racura Oncology (ASX: RAC) stock up 12.21% as MYC silencing data builds case for bisantrene relaunch
MYC is the undruggable cancer gene. Racura Oncology (ASX: RAC) says bisantrene silences it via G4 stabilisation. Three clinical trials, A$19m cash, and a 2027 inflection ahead.
Former MADD CEO Debbie Weir joins Cancer Vaccine Coalition to accelerate therapeutic cancer vaccine movement
Debbie Weir, former MADD CEO, joins Cancer Vaccine Coalition to accelerate clinical trials and advocacy for therapeutic cancer vaccines in the U.S.